LAMIVUDINE

Product NDC: 69097-167
11-digit product format: 690970167
Labeler code: 69097
Product ID: 69097-167_65d03051-a84c-49d7-928b-515cb1769bec
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LAMIVUDINE
Dosage form: TABLET
Route: ORAL
Labeler: Cipla USA Inc.
Application: ANDA077221
Marketing category: ANDA
Marketing start: 2017-03-03
Marketing end: 0000-00-00
Substance: LAMIVUDINE
Active strength: 300 mg/1
Pharmacologic classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	69097-167		D	Discontinued by firm		2026-10-12
excluded package	package	69097-167	69097-167-02	D	Discontinued by firm		2026-10-12

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077221-001	LAMIVUDINE	LAMIVUDINE	150MG	TABLET / ORAL	AB		2017-03-03
A077221-002	LAMIVUDINE	LAMIVUDINE	300MG	TABLET / ORAL	AB		2017-03-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077221-001	AB
A077221-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2022-09-29 23:25 UTC	2022-09	A077221-001	LAMIVUDINE	150MG	TABLET / ORAL	AB	2017-03-03	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A077221-002	LAMIVUDINE	300MG	TABLET / ORAL	AB	2017-03-03	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077221-001	LAMIVUDINE	150MG	TABLET / ORAL	AB	2017-03-03	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077221-002	LAMIVUDINE	300MG	TABLET / ORAL	AB	2017-03-03	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A077221-001	LAMIVUDINE	150MG	TABLET / ORAL	AB	2017-03-03	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A077221-002	LAMIVUDINE	300MG	TABLET / ORAL	AB	2017-03-03	`a50c72e98297…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A077221-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077221-002	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077221-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077221-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077221-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077221-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077221-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077221-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077221-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077221-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077221-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077221-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077221-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077221-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077221-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077221-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077221-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077221-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077221-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077221-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077221-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077221-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077221-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077221-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077221-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077221-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077221-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077221-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077221-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077221-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077221-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077221-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077221-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077221-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077221-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077221-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077221-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077221-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077221-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077221-002	AB	1	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69097-167	LAMIVUDINE TABLET [CIPLA USA INC.]	9	Legacy NDC	20190610_36b83d9a-962f-4821-bf44-0bace705b620.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2T8Q726O95	LAMIVUDINE	134678-17-4	LAMIVUDINE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
69097-167-02	69097016702	30 TABLET in 1 BOTTLE (69097-167-02)	30 tablet	2017-03-03	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LAMIVUDINE	Cipla USA Inc. \| Cipla Kurkumbh \| Cipla Ltd.- Goa	2019-06-04	HUMAN PRESCRIPTION DRUG LABEL	9